Disclosures for "Bilateral Vestibulopathy: Strong Association With the ZNF91/LINC01224 Locus "
-
Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio.
-
Felix Heindl has nothing to disclose.
-
Prof. Zwergal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dr. Willmar Schwabe GmbH. Prof. Zwergal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Dr. Willmar Schwabe GmbH. Prof. Zwergal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Prof. Zwergal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. The institution of Prof. Zwergal has received research support from Dr. Willmar Schwabe GmbH. The institution of Prof. Zwergal has received research support from Cures Within Reach.
-
Annette Hartmann has nothing to disclose.
-
Dan Rujescu has nothing to disclose.